Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

Details for Australian Patent Application No. 2004202565 (hide)

Owner Abbott Laboratories

Inventors Xin, Zhili; Zhu, Gui-Dong; Pei, Zhonghua; Geldern, Tom Von; Winn, Martin; Lynch, John K; Staeger, Michael A; Link, James; Gunawardana, Indrani W; Jae, Hwan-Soo; Liu, Gang; Boyd, Steven A; Freeman, Jennifer C

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004202565

Parent 771126

Filing date 10 June 2004

Wipo publication date 8 July 2004

Acceptance publication date 19 July 2007

International Classifications

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/404 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/417 (2006.01)

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/443 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

A61K 31/453 (2006.01)

A61K 31/454 (2006.01)

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 - not condensed and containing further heterocyclic rings

Event Publications

1 July 2004 Complete Application Filed

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2004202565

19 July 2007 Application Accepted

  Published as AU-B-2004202565

15 November 2007 Standard Patent Sealed

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004202566-Method for Producing Human Antibodies with Properties of Agonist, Antagonist, or Inverse Agonist

2004202564-Improvement to Fasteners